Published in

Elsevier, Value in Health, (23), p. S496, 2020

DOI: 10.1016/j.jval.2020.08.547

Links

Tools

Export citation

Search in Google Scholar

PCV56 Cost-Effectiveness Analysis of Apixaban in Atrial Fibrillation Indication: Iraq (Private Sector)

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO